Top Markets
#1 Akedo Akedo +58.47%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.71%
#4 Cross Cross +45.85%
#5 Black Phoenix Black Phoenix +34.29%
#6 Velvet Velvet +30.75%
#7 OVERTAKE OVERTAKE +19.61%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.83%
#9 Cap Cap +15.18%
#10 QANplatform QANplatform +14.92%
Coin of the day
Akedo Akedo
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Solarvest BioEnergy Inc. Solarvest BioEnergy Inc.

Solarvest BioEnergy Inc.

SVS
Classifica tra le azioni #38865
Solarvest BioEnergy Inc. specializes in harnessing algal-based production... Solarvest BioEnergy Inc. specializes in harnessing algal-based production systems to develop natural, environmentally friendly commercial products for both Canadian and international markets. The company's offerings span human nutrition, including omega-3; a clean energy solution for continuous hydrogen production; and pharmaceutical components for human health. These pharmaceutical applications specifically include cannabinoids derived from algae and bone morphogenetic protein for treating bone fractures. Solarvest BioEnergy Inc. also has a collaborative research and development agreement with FSD Pharma Inc. to create pharmaceutical-grade cannabinoids using algae. Established in 2005, the company is headquartered in Vancouver, Canada.
Prezzo delle azioni
$0.01823546
Ultima sincronizzazione: 2023-10-03
Capitalizzazione di mercato
$767.12K
Variazione (1 giorno)
-0.22%
Variazione (1 anno)
0.00%
Paese
CA
Scambia Solarvest BioEnergy Inc. (SVS)

Categoria

Healthcare
Rapporto P/S per Solarvest BioEnergy Inc. (SVS)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Solarvest BioEnergy Inc., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Solarvest BioEnergy Inc. da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE